Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sanuwave Health Inc. (SNWV : NSDQ)

• Company Description    SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. Number of Employees: 46

• Price / Volume Information    Yesterday's Closing Price: $37.02 Daily Weekly Monthly 20 Day Moving Average: 39,591 shares Shares Outstanding: 8.57 (millions) Market Capitalization: $317.19 (millions) Beta: 1.39 52 Week High: $46.59 52 Week Low: $0.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.01% -3.78% 12 Week 12.18% 1.85% Year To Date 60.96% 43.71%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 11495 Valley View Road - Eden Prairie,MN 55344 USA ph: 952-656-1029 fax: 770-419-8634 investors@sanuwave.com http://www.sanuwave.com

• General Corporate Information    Officers Morgan Frank - Chief Executive Officer; Chairman of the Board Andrew Walko - President Peter Stegagno - Chief Operating Officer Peter Sorensen - Chief Financial Officer Tim Wern - Executive Vice President Peer Information Sanuwave Health Inc. (BJCT) Sanuwave Health Inc. (CADMQ) Sanuwave Health Inc. (APNO) Sanuwave Health Inc. (UPDC) Sanuwave Health Inc. (IMTIQ) Sanuwave Health Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 80303D305 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 8.57 Most Recent Split Date: 10.00 (0.00:1) Beta: 1.39 Market Capitalization: $317.19 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.37 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.26 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: 142.38 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 8.09 EPS Growth vs. Year Ago Period: -99.73% vs. Previous Quarter: 101.52% Sales Growth vs. Year Ago Period: 41.92% vs. Previous Quarter: 8.80% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -135.15 03/31/25 - -145.76 12/31/24 - -152.39 Current Ratio 06/30/25 - 0.43 03/31/25 - 0.40 12/31/24 - 0.43 Quick Ratio 06/30/25 - 0.31 03/31/25 - 0.28 12/31/24 - 0.34 Operating Margin 06/30/25 - -99.89 03/31/25 - -104.55 12/31/24 - -112.42 Net Margin 06/30/25 - -97.03 03/31/25 - -89.86 12/31/24 - -96.13 Pre-Tax Margin 06/30/25 - -96.96 03/31/25 - -89.78 12/31/24 - -96.05 Book Value 06/30/25 - -1.72 03/31/25 - -2.02 12/31/24 - -1.49 Inventory Turnover 06/30/25 - 1.85 03/31/25 - 2.15 12/31/24 - 2.53 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©